Small doses, big hope: new therapy may help toddlers beat nut allergies
NCT ID NCT05049512
First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This study tested a low-dose oral immunotherapy (OIT) treatment for young children aged 18-36 months with allergies to two nuts. Over 18 months, one group received daily tiny doses of the nuts they were allergic to, while the other group avoided them completely. The goal was to see if the treatment helped children tolerate the nuts without reacting, even after stopping treatment for a few weeks. The study included 12 children in an initial pilot phase.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGY, NUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
Conditions
Explore the condition pages connected to this study.